| Date Filed | Type | Description |
| 10/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| Dunne Michael W. (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Exercised 1,779 options to buy
@ $0 |
|
| 07/03/2023 |
4
| HUNT RONALD (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Exercised 2,796 options to buy
@ $0 |
|
| 06/15/2023 |
4
| Hecht Beth (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Exercised 15,853 options to buy
@ $0 |
|
| 06/15/2023 |
4
| Dunne Michael W. (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Exercised 15,853 options to buy
@ $0 |
|
| 06/15/2023 |
4
| Chin Mark (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Exercised 15,853 options to buy
@ $0 |
|
| 04/03/2023 |
4
| HUNT RONALD (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Exercised 2,041 options to buy
@ $0 |
|
| 04/03/2023 |
4
| Matthews Judith M. (CFO) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Granted 100,000 options to buy
@ $1, valued at
$100k
|
|
| 04/03/2023 |
4
| Puttagunta Sailaja (Chief Medical Officer) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Granted 75,000 options to buy
@ $1, valued at
$75k
|
|
| 04/03/2023 |
4
| Dunne Michael W. (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Exercised 1,299 options to buy
@ $0 |
|
| 04/03/2023 |
4
| Fishman Corey N. (CEO) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Granted 275,000 options to buy
@ $1, valued at
$275k
|
|
| 03/14/2023 |
4
| Matthews Judith M. (CFO) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Granted 6,666 shares
@ $0
Paid exercise price by delivering 2,883 shares
@ $0.96, valued at
$2.8k
Exercised 6,666 options to buy
@ $0 |
|
| 03/14/2023 |
4
| Fishman Corey N. (CEO) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Granted 14,333 shares
@ $0
Paid exercise price by delivering 5,683 shares
@ $0.96, valued at
$5.5k
Exercised 14,333 options to buy
@ $0 |
|
| 02/27/2023 |
4/A
| Dunne Michael W. (Director) has filed a Form 4 on Iterum Therapeutics plc |
| 01/04/2023 |
4
| Dunne Michael W. (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Exercised 761 options to buy
@ $0 |
|
| 01/04/2023 |
4
| HUNT RONALD (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Exercised 1,197 options to buy
@ $0 |
|
| 12/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2022 |
4
| Ahrens Brenton Karl (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Granted 14,838 options to buy
@ $1.59, valued at
$23.6k
|
|
| 09/27/2022 |
4
| Dunne Michael W. (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Granted 1,779 options to buy
@ $0 |
|
| 09/27/2022 |
4
| HUNT RONALD (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Granted 2,796 options to buy
@ $0 |
|
| 09/20/2022 |
4
| Ahrens Brenton Karl (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Sold 15,000 shares
@ $1.9028, valued at
$28.5k
Sold 15,000 shares
@ $1.7652, valued at
$26.5k
Sold 7,246 shares
@ $1.7817, valued at
$12.9k
|
|
| 09/15/2022 |
4
| Ahrens Brenton Karl (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Sold 15,000 shares
@ $2.1412, valued at
$32.1k
Sold 15,000 shares
@ $2.0971, valued at
$31.5k
Sold 15,000 shares
@ $2.0181, valued at
$30.3k
|
|
| 09/12/2022 |
4
| Ahrens Brenton Karl (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Sold 3,298 shares
@ $2.2635, valued at
$7.5k
Sold 15,000 shares
@ $2.3153, valued at
$34.7k
Sold 15,000 shares
@ $2.3072, valued at
$34.6k
|
|
| 09/09/2022 |
4
| Dunne Michael W. (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Bought 10,000 shares
@ $2.22, valued at
$22.2k
|
|
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|